Other Species / Isoforms
  SIPA1L2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S19-p
HKLGRASsKFKDPPR
0 1
SIPA1L2 (human) HKLGRASsKFKDPPR S19-p
SIPA1L2 (mouse) HKLGRAAAKLKDPSR A19
SIPA1L2 (rat) HKLGRAASKFKDPSR S19
S30-p
DPPRIMQsDDyFARK
0 1
SIPA1L2 (human) DPPRIMQsDDyFARK S30-p
SIPA1L2 (mouse) DPSRTMQADDYFARK A30
SIPA1L2 (rat) DPSRAMQSDDYFARK S30
Y33-p
RIMQsDDyFARKFKA
0 87
SIPA1L2 (human) RIMQsDDyFARKFKA Y33-p
SIPA1L2 (mouse) RTMQADDYFARKFKA Y33
SIPA1L2 (rat) RAMQSDDYFARKFKA Y33
T68
GGGPANGTPAVPKMG
0 1
SIPA1L2 (human) GGGPANGTPAVPKMG T68
SIPA1L2 (mouse) GGGPANGtPAVPKMG T69-p
SIPA1L2 (rat) GGGPANGTPAVPKMG T69
T140-p
DFVEAKYtIGDIFVH
0 2
SIPA1L2 (human) DFVEAKYtIGDIFVH T140-p
SIPA1L2 (mouse) DFVEAKYTIGDIFVH T141
SIPA1L2 (rat) DFVEAKYTIGDIFVH T141
S148-p
IGDIFVHsPQRGLHP
Upstream
0 41
Treatment
  • EGF
  • ischemia
  • nocodazole
  • rapamycin
SIPA1L2 (human) IGDIFVHsPQRGLHP S148-p
SIPA1L2 (mouse) IGDIFVHsPQRGLHP S149-p
SIPA1L2 (rat) IGDIFVHsPQRGLHP S149-p
S160-p
LHPIRQRsNsDVTIS
0 2
SIPA1L2 (human) LHPIRQRsNsDVTIS S160-p
SIPA1L2 (mouse) LHPIRQRSNsDItIS S161
SIPA1L2 (rat) LHPIRQRSNSDITIS S161
S162-p
PIRQRsNsDVTISDI
0 16
SIPA1L2 (human) PIRQRsNsDVTISDI S162-p
SIPA1L2 (mouse) PIRQRSNsDItISDI S163-p
SIPA1L2 (rat) PIRQRSNSDITISDI S163
T165
QRsNsDVTISDIDAE
0 1
SIPA1L2 (human) QRsNsDVTISDIDAE T165
SIPA1L2 (mouse) QRSNsDItISDIDTE T166-p
SIPA1L2 (rat) QRSNSDITISDIDTE T166
Y192-p
GAALHREyGsTSSID
0 2
SIPA1L2 (human) GAALHREyGsTSSID Y192-p
SIPA1L2 (mouse) GAALHREyGstssID Y193-p
SIPA1L2 (rat) GAALHREYGSTSSID Y193
S194-p
ALHREyGsTSSIDRQ
0 15
SIPA1L2 (human) ALHREyGsTSSIDRQ S194-p
SIPA1L2 (mouse) ALHREyGstssIDRQ S195-p
SIPA1L2 (rat) ALHREYGSTSSIDRQ S195
T195
LHREyGsTSSIDRQG
0 1
SIPA1L2 (human) LHREyGsTSSIDRQG T195
SIPA1L2 (mouse) LHREyGstssIDRQG T196-p
SIPA1L2 (rat) LHREYGSTSSIDRQG T196
S196
HREyGsTSSIDRQGL
0 1
SIPA1L2 (human) HREyGsTSSIDRQGL S196
SIPA1L2 (mouse) HREyGstssIDRQGL S197-p
SIPA1L2 (rat) HREYGSTSSIDRQGL S197
S197
REyGsTSSIDRQGLS
0 2
SIPA1L2 (human) REyGsTSSIDRQGLS S197
SIPA1L2 (mouse) REyGstssIDRQGLS S198-p
SIPA1L2 (rat) REYGSTSSIDRQGLS S198
Y220-p
RGYRVENyDHkAMVP
0 5
SIPA1L2 (human) RGYRVENyDHkAMVP Y220-p
SIPA1L2 (mouse) RGYRIESYDPKVTGS Y221
SIPA1L2 (rat) RGYRIESYDPKVTSS Y221
K223-ub
RVENyDHkAMVPFGF
0 1
SIPA1L2 (human) RVENyDHkAMVPFGF K223-ub
SIPA1L2 (mouse) RIESYDPKVTGSFGF K224
SIPA1L2 (rat) RIESYDPKVTSSFGF K224
S241-p
FRCDPAIsPSLHAAA
0 1
SIPA1L2 (human) FRCDPAIsPSLHAAA S241-p
SIPA1L2 (mouse) FPCDTAISPSLHAAA S242
SIPA1L2 (rat) FPCDTAISPSLHAAA S242
Y263-p
VRISGLDyVDSALLM
0 21
SIPA1L2 (human) VRISGLDyVDSALLM Y263-p
SIPA1L2 (mouse) VRISGLDyMDGGLLM Y264-p
SIPA1L2 (rat) VRISGLDYMDGGLLM Y264
K283-ub
KPFKRRLksESVETS
0 1
SIPA1L2 (human) KPFKRRLksESVETS K283-ub
SIPA1L2 (mouse) KPFKRRLKsESVETS K284
SIPA1L2 (rat) KPFKRRLKSESVETS K284
S284-p
PFKRRLksESVETSL
0 5
SIPA1L2 (human) PFKRRLksESVETSL S284-p
SIPA1L2 (mouse) PFKRRLKsESVETSL S285-p
SIPA1L2 (rat) PFKRRLKSESVETSL S285
S300-p
RKLRTVKsEHETFKF
0 2
SIPA1L2 (human) RKLRTVKsEHETFKF S300-p
SIPA1L2 (mouse) RKLRAVKSEHETFKF S301
SIPA1L2 (rat) RKLRTVKSEHETFKF S301
S379-p
GQTGNCEsPLGsKED
0 7
SIPA1L2 (human) GQTGNCEsPLGsKED S379-p
SIPA1L2 (mouse) GPAGGCEsPLGsKED S380-p
SIPA1L2 (rat) GPAGGCESPLGSKED S380
S383-p
NCEsPLGsKEDLNSK
0 6
SIPA1L2 (human) NCEsPLGsKEDLNSK S383-p
SIPA1L2 (mouse) GCEsPLGsKEDLNSK S384-p
SIPA1L2 (rat) GCESPLGSKEDLNAK S384
K401-ub
DADEGDGkSNDLVLS
0 1
SIPA1L2 (human) DADEGDGkSNDLVLS K401-ub
SIPA1L2 (mouse) DADEGDGKSNDLVLS K402
SIPA1L2 (rat) DADEGDGKSNDLVLS K402
Y475-p
HREKVKRyIIEHIDL
0 1
SIPA1L2 (human) HREKVKRyIIEHIDL Y475-p
SIPA1L2 (mouse) HREKVKRYIIEHVDL Y476
SIPA1L2 (rat) HREKVKRYIIEHVDL Y476
Y485-p
EHIDLGAyYyRKFFY
0 1
SIPA1L2 (human) EHIDLGAyYyRKFFY Y485-p
SIPA1L2 (mouse) EHVDLGAYYYRKFFY Y486
SIPA1L2 (rat) EHVDLGAYYYRKFFY Y486
Y487-p
IDLGAyYyRKFFYGK
0 1
SIPA1L2 (human) IDLGAyYyRKFFYGK Y487-p
SIPA1L2 (mouse) VDLGAYYYRKFFYGK Y488
SIPA1L2 (rat) VDLGAYYYRKFFYGK Y488
K590-ub
RQASNSPkVSEQLLk
0 2
SIPA1L2 (human) RQASNSPkVSEQLLk K590-ub
SIPA1L2 (mouse) RQAANSPKVPEQLLK K591
SIPA1L2 (rat) RQAANSPKVPEQLLK K591
K597-ub
kVSEQLLkLDEQGLS
0 1
SIPA1L2 (human) kVSEQLLkLDEQGLS K597-ub
SIPA1L2 (mouse) KVPEQLLKLDEQGLS K598
SIPA1L2 (rat) KVPEQLLKLDEQGLS K598
K660-ub
YRAQLDNkTDSTGTH
0 1
SIPA1L2 (human) YRAQLDNkTDSTGTH K660-ub
SIPA1L2 (mouse) YRAQLDNKTDSTGTH K661
SIPA1L2 (rat) YRAQLDNKTDSTGTH K661
K766-ub
PFGPPIPkGVTFPkS
0 1
SIPA1L2 (human) PFGPPIPkGVTFPkS K766-ub
SIPA1L2 (mouse) PFGPPIPKGVTFPKS K767
SIPA1L2 (rat) PFVPPIPKGVTFPRT K767
K772-ub
PkGVTFPkSAVFRDF
0 1
SIPA1L2 (human) PkGVTFPkSAVFRDF K772-ub
SIPA1L2 (mouse) PKGVTFPKSAVFRDF K773
SIPA1L2 (rat) PKGVTFPRTGVFRDF R773
Y808-p
ATRTRQEyLKDLAEN
0 1
SIPA1L2 (human) ATRTRQEyLKDLAEN Y808-p
SIPA1L2 (mouse) ATRTRQEYLKDLAEN Y809
SIPA1L2 (rat) ATRTRHEYLKDLAEN Y809
S1029-p
IQPHDDGsPRRGCSE
Upstream
0 12
Treatment
  • nocodazole
SIPA1L2 (human) IQPHDDGsPRRGCSE S1029-p
SIPA1L2 (mouse) IQPHEDGsPRRGCSE S1030-p
SIPA1L2 (rat) IQPHEDGSPRRGCSE S1030
K1046-ub
RIPMVEYkLDSEGTP
0 1
SIPA1L2 (human) RIPMVEYkLDSEGTP K1046-ub
SIPA1L2 (mouse) RIPMVEYKLDSEGTP K1047
SIPA1L2 (rat) RIPMVEYKLDSEGTP K1047
K1057-ub
EGTPCEYkTPFRRNT
0 1
SIPA1L2 (human) EGTPCEYkTPFRRNT K1057-ub
SIPA1L2 (mouse) EGTPCEYKTPFRRNT K1058
SIPA1L2 (rat) EGTPCEYKTPFRRNT K1058
T1065-p
TPFRRNTtWHRVPtP
0 1
SIPA1L2 (human) TPFRRNTtWHRVPtP T1065-p
SIPA1L2 (mouse) TPFRRNTTWHRVPTP T1066
SIPA1L2 (rat) TPFRRNTTWHRVPTP T1066
T1071-p
TtWHRVPtPALQPLS
0 3
SIPA1L2 (human) TtWHRVPtPALQPLS T1071-p
SIPA1L2 (mouse) TTWHRVPTPALQPVs T1072
SIPA1L2 (rat) TTWHRVPTPALQPVS T1072
S1078
tPALQPLSRAsPIPG
0 1
SIPA1L2 (human) tPALQPLSRAsPIPG S1078
SIPA1L2 (mouse) TPALQPVsRAsPVPG S1079-gl
SIPA1L2 (rat) TPALQPVSRASPVPG S1079
S1081-p
LQPLSRAsPIPGtPD
Upstream
0 12
Treatment
  • selumetinib
  • vemurafenib
SIPA1L2 (human) LQPLSRAsPIPGtPD S1081-p
SIPA1L2 (mouse) LQPVsRAsPVPGTPD S1082-p
SIPA1L2 (rat) LQPVSRASPVPGTPD S1082
T1086-p
RAsPIPGtPDRLPCQ
0 2
SIPA1L2 (human) RAsPIPGtPDRLPCQ T1086-p
SIPA1L2 (mouse) RAsPVPGTPDRLQCQ T1087
SIPA1L2 (rat) RASPVPGTPDRLQCQ T1087
T1107
QAAIPRSTSFDRKLP
0 1
SIPA1L2 (human) QAAIPRSTSFDRKLP T1107
SIPA1L2 (mouse) QAAIPRStSFDRKLP T1108-p
SIPA1L2 (rat) QAAIPRSTSFDRKLP T1108
K1189-ub
KWHGPPSkVLGsYkE
0 1
SIPA1L2 (human) KWHGPPSkVLGsYkE K1189-ub
SIPA1L2 (mouse) KWHGPPSKVLSSYKE K1190
SIPA1L2 (rat) KWHGPPSKVLSSYKE K1190
S1193-p
PPSkVLGsYkERALQ
0 1
SIPA1L2 (human) PPSkVLGsYkERALQ S1193-p
SIPA1L2 (mouse) PPSKVLSSYKERVLQ S1194
SIPA1L2 (rat) PPSKVLSSYKERALQ S1194
K1195-ub
SkVLGsYkERALQKD
0 1
SIPA1L2 (human) SkVLGsYkERALQKD K1195-ub
SIPA1L2 (mouse) SKVLSSYKERVLQKD K1196
SIPA1L2 (rat) SKVLSSYKERALQKD K1196
S1244-p
SDDKHFGsGDLMDPE
0 9
SIPA1L2 (human) SDDKHFGsGDLMDPE S1244-p
SIPA1L2 (mouse) SDDKHFGsGDLMDPE S1245-p
SIPA1L2 (rat) SDDKHFGsGDLMDPE S1245-p
Y1257-p
PELLGLTyIKGASTD
0 1
SIPA1L2 (human) PELLGLTyIKGASTD Y1257-p
SIPA1L2 (mouse) PELLGLTYIKGASTD Y1258
SIPA1L2 (rat) PELLGLTYIKGASTD Y1258
T1276-p
TAPCMPAtILGPVHL
0 1
SIPA1L2 (human) TAPCMPAtILGPVHL T1276-p
SIPA1L2 (mouse) TTPCMPATILGPVHL T1277
SIPA1L2 (rat) TTPCMPATILGPMHL T1277
S1286-p
GPVHLAGsRSLIHSR
0 2
SIPA1L2 (human) GPVHLAGsRSLIHSR S1286-p
SIPA1L2 (mouse) GPVHLTGSRSLMHSR S1287
SIPA1L2 (rat) GPMHLTGSRSLIHSR S1287
S1304-p
WADAADVsGPDDEPA
0 2
SIPA1L2 (human) WADAADVsGPDDEPA S1304-p
SIPA1L2 (mouse) WADAADVSVADDDPA S1305
SIPA1L2 (rat) WADAADVSGADEDPA S1305
Y1314-p
DDEPAKLySVHGYAS
0 1
SIPA1L2 (human) DDEPAKLySVHGYAS Y1314-p
SIPA1L2 (mouse) DDDPAKMYALHGYAS Y1315
SIPA1L2 (rat) DEDPAKMYTLHGYAS Y1315
Y1369-p
SLDSSKVyIVSHSSG
0 2
SIPA1L2 (human) SLDSSKVyIVSHSSG Y1369-p
SIPA1L2 (mouse) SLDSSKVYIVTHGGG Y1369
SIPA1L2 (rat) SLDSSKVYIVTHSGG Y1369
Y1387-p
PGSMSKPyHRQGAVN
0 2
SIPA1L2 (human) PGSMSKPyHRQGAVN Y1387-p
SIPA1L2 (mouse) PGAVTKPYHRQGAAN Y1387
SIPA1L2 (rat) PGAVAKPYHRQGAAN Y1387
K1401
NKYVIGWKKSEGSPP
0 3
SIPA1L2 (human) NKYVIGWKKSEGSPP K1401
SIPA1L2 (mouse) NKYVIGWkKsEGsPP K1401-ac
SIPA1L2 (rat) NKYVIGWKKSEGSPP K1401
S1403
YVIGWKKSEGSPPPE
0 1
SIPA1L2 (human) YVIGWKKSEGSPPPE S1403
SIPA1L2 (mouse) YVIGWkKsEGsPPPE S1403-p
SIPA1L2 (rat) YVIGWKKSEGSPPPE S1403
S1406
GWKKSEGSPPPEEPE
0 8
SIPA1L2 (human) GWKKSEGSPPPEEPE S1406
SIPA1L2 (mouse) GWkKsEGsPPPEEPE S1406-p
SIPA1L2 (rat) GWKKSEGSPPPEEPE S1406
S1461-p
LKLMLPDsPLVEEGR
Upstream
0 32
Treatment
  • angiotensin_2
  • anti-CD3
  • ischemia
  • selumetinib
  • SII_angiotensin_2
  • vemurafenib
SIPA1L2 (human) LKLMLPDsPLVEEGR S1461-p
SIPA1L2 (mouse) LKLMLPDsPLVEEGR S1461-p
SIPA1L2 (rat) LKLMLPDsPLVEEGR S1461-p
S1472-p
EEGRRKFsFyGNLsP
0 14
SIPA1L2 (human) EEGRRKFsFyGNLsP S1472-p
SIPA1L2 (mouse) EEGRRKFsFYGNVsP S1472-p
SIPA1L2 (rat) EEGRRKFSFYGNLsP S1472
Y1474-p
GRRKFsFyGNLsPRR
0 5
SIPA1L2 (human) GRRKFsFyGNLsPRR Y1474-p
SIPA1L2 (mouse) GRRKFsFYGNVsPRR Y1474
SIPA1L2 (rat) GRRKFSFYGNLsPRR Y1474
S1478-p
FsFyGNLsPRRSLYR
Upstream
0 46
Treatment
  • BI2536
  • ischemia
SIPA1L2 (human) FsFyGNLsPRRSLYR S1478-p
SIPA1L2 (mouse) FsFYGNVsPRRSLYR S1478-p
SIPA1L2 (rat) FSFYGNLsPRRSLYR S1478-p
T1486-p
PRRSLYRtLsDESIC
Upstream
0 1
Treatment
  • BI2536
SIPA1L2 (human) PRRSLYRtLsDESIC T1486-p
SIPA1L2 (mouse) PRRSLYRTLsDEsVC T1486
SIPA1L2 (rat) PRRSLYRTLsDESVC T1486
S1488-p
RSLYRtLsDESICSN
Upstream
0 61
Treatment
  • BI2536
SIPA1L2 (human) RSLYRtLsDESICSN S1488-p
SIPA1L2 (mouse) RSLYRTLsDEsVCSN S1488-p
SIPA1L2 (rat) RSLYRTLsDESVCSN S1488-p
S1491
YRtLsDESICSNRRG
0 3
SIPA1L2 (human) YRtLsDESICSNRRG S1491
SIPA1L2 (mouse) YRTLsDEsVCSNRRG S1491-p
SIPA1L2 (rat) YRTLsDESVCSNRRG S1491
S1499-p
ICSNRRGsSFGSSRS
0 3
SIPA1L2 (human) ICSNRRGsSFGSSRS S1499-p
SIPA1L2 (mouse) VCSNRRGsSFASSRS S1499-p
SIPA1L2 (rat) VCSNRRGSSFASSRS S1499
S1520-p
LPNDILFsttPPyHs
0 13
SIPA1L2 (human) LPNDILFsttPPyHs S1520-p
SIPA1L2 (mouse) LPNDILFSTtPPYHS S1520
SIPA1L2 (rat) LPNDILFSTTPPYHS S1520
T1521-p
PNDILFsttPPyHsT
0 12
SIPA1L2 (human) PNDILFsttPPyHsT T1521-p
SIPA1L2 (mouse) PNDILFSTtPPYHST T1521
SIPA1L2 (rat) PNDILFSTTPPYHST T1521
T1522-p
NDILFsttPPyHsTL
0 15
SIPA1L2 (human) NDILFsttPPyHsTL T1522-p
SIPA1L2 (mouse) NDILFSTtPPYHSTL T1522-p
SIPA1L2 (rat) NDILFSTTPPYHSTL T1522
Y1525-p
LFsttPPyHsTLPPR
0 4
SIPA1L2 (human) LFsttPPyHsTLPPR Y1525-p
SIPA1L2 (mouse) LFSTtPPYHSTLPPR Y1525
SIPA1L2 (rat) LFSTTPPYHSTLPPR Y1525
S1527-p
sttPPyHsTLPPRAH
0 5
SIPA1L2 (human) sttPPyHsTLPPRAH S1527-p
SIPA1L2 (mouse) STtPPYHSTLPPRTH S1527
SIPA1L2 (rat) STTPPYHSTLPPRTH S1527
S1538-p
PRAHPAPsMGsLRNE
0 3
SIPA1L2 (human) PRAHPAPsMGsLRNE S1538-p
SIPA1L2 (mouse) PRTHPAPSMGSLRNE S1538
SIPA1L2 (rat) PRTHPAPSMGSLRNE S1538
S1541-p
HPAPsMGsLRNEFWF
0 2
SIPA1L2 (human) HPAPsMGsLRNEFWF S1541-p
SIPA1L2 (mouse) HPAPSMGSLRNEFWF S1541
SIPA1L2 (rat) HPAPSMGSLRNEFWF S1541
S1549-p
LRNEFWFsDGsLsDk
Upstream
0 13
Treatment
  • anti-CD3
SIPA1L2 (human) LRNEFWFsDGsLsDk S1549-p
SIPA1L2 (mouse) LRNEFWFsDGsLSDK S1549-p
SIPA1L2 (rat) LRNEFWFsDGsLSDK S1549-p
S1552-p
EFWFsDGsLsDkSkC
0 8
SIPA1L2 (human) EFWFsDGsLsDkSkC S1552-p
SIPA1L2 (mouse) EFWFsDGsLSDKSKC S1552-p
SIPA1L2 (rat) EFWFsDGsLSDKSKC S1552-p
S1554-p
WFsDGsLsDkSkCAD
0 1
SIPA1L2 (human) WFsDGsLsDkSkCAD S1554-p
SIPA1L2 (mouse) WFsDGsLSDKSKCAD S1554
SIPA1L2 (rat) WFsDGsLSDKSKCAD S1554
K1556-ub
sDGsLsDkSkCADPG
0 1
SIPA1L2 (human) sDGsLsDkSkCADPG K1556-ub
SIPA1L2 (mouse) sDGsLSDKSKCADPG K1556
SIPA1L2 (rat) sDGsLSDKSKCADPG K1556
K1558-ub
GsLsDkSkCADPGLM
0 2
SIPA1L2 (human) GsLsDkSkCADPGLM K1558-ub
SIPA1L2 (mouse) GsLSDKSKCADPGLM K1558
SIPA1L2 (rat) GsLSDKSKCADPGLM K1558
S1591
RAFEGLDSDEELGLL
0 2
SIPA1L2 (human) RAFEGLDSDEELGLL S1591
SIPA1L2 (mouse) RAFEGLDsDEELGLL S1591-p
SIPA1L2 (rat) RAFEGLDSDEELGLL S1591
S1611-p
YLDQRVAsFCTLTDM
0 2
SIPA1L2 (human) YLDQRVAsFCTLTDM S1611-p
SIPA1L2 (mouse) YLDQRVAsFCTLTDL S1611-p
SIPA1L2 (rat) YLDQRVASFCTLTDL S1611
S1650-p
MDTTGERsPsPLTGK
Upstream
0 8
Treatment
  • selumetinib
  • vemurafenib
SIPA1L2 (human) MDTTGERsPsPLTGK S1650-p
SIPA1L2 (mouse) MDTPGERsPSTLTGK S1650-p
SIPA1L2 (rat) MDTPGERSPSTLTGK S1650
S1652-p
TTGERsPsPLTGKVN
Upstream
0 7
Treatment
  • nocodazole
SIPA1L2 (human) TTGERsPsPLTGKVN S1652-p
SIPA1L2 (mouse) TPGERsPSTLTGKVN S1652
SIPA1L2 (rat) TPGERSPSTLTGKVN S1652
K1679-ub
LRKEKQDkAVLQAEV
0 1
SIPA1L2 (human) LRKEKQDkAVLQAEV K1679-ub
SIPA1L2 (mouse) LRKEKQDKAVLQAEV K1679
SIPA1L2 (rat) LRKEKQDKAVLQAEV K1679